Cell Impact AB (publ) (ICL) Stock Price & News

All values in SEK	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	481.00K	1.11M	2.19M	1.50M
Cost of goods sold	1.38M	3.04M	981.00K	-316.00K
Cost of revenue	1.38M	3.04M	981.00K	-316.00K
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	10.08M	12.36M	11.21M	12.87M
Operating expense	20.81M	63.51M	17.77M	19.18M
Total operating expenses	22.18M	66.55M	18.75M	18.86M
Operating income	-21.70M	-65.44M	-16.56M	-17.36M
Other non operating income	-2.00K	370.00K	1.00K	-1.00K
EBT including unusual items	-22.77M	-66.44M	-18.45M	-17.66M
EBT excluding unusual items	-22.77M	-66.44M	-18.45M	-17.66M
Income tax expense	42.00K	-40.00K	40.00K	-8.00K
Effective tax rate	-0.18%	0.06%	-0.22%	0.05%
Other operating expenses	2.82M	147.00K	289.00K	116.00K
Net income	-22.82M	-66.40M	-18.49M	-17.65M
Net profit margin	-4,743.45%	-5,965.50%	-842.95%	-1,174.25%
Earnings per share	-	-	-	-
Interest and investment income	-	210.00K	-	-
Interest expense	-1.07M	-1.35M	-1.89M	-296.00K
Net interest expenses	-1.07M	-1.14M	-1.89M	-296.00K
Depreciation and amortization charges	7.91M	51.01M	6.28M	6.20M
EBITDA	-13.80M	-64.99M	-10.28M	-11.16M
Gain or loss from assets sale	-	2.99M	-	-

Finance